Recent Updates
Recently added Catalysts
ANIX Positive Sentiment Score: 75/100

Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank

Monday, March 13, 2023 2 min read
Key Takeaway: Anixa Biosciences, Inc. announced that it does not hold any accounts at the collapsed Silicon Valley Bank, providing reassurance to its shareholders. The biotechnology company is focused on cancer treatment, with ongoing projects like a CAR-T technology for ovarian cancer and vaccines for breast and ovarian cancer. Anixa's approach involves collaboration with prestigious institutions to develop and commercialize its therapeutic innovations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Anixa Biosciences has reassured shareholders regarding financial stability.
  • The company has innovative cancer treatment technologies, including CAR-T and vaccine developments.
  • Partnerships with leading research institutions enhance their clinical development.

Full Press Release Details

SAN JOSE, Calif., March 13, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today reassured its shareholders and the investment community that it does not have any accounts at recently collapsed Silicon Valley Bank.
About Anixa Biosciences, Inc.
Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company's vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer – specifically triple negative breast cancer (TNBC), the most lethal form of the disease – as well as a vaccine to prevent ovarian cancer. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms of cancer. Anixa's unique business model of partnering with world-renowned research institutions on clinical development allows the company to continually examine emerging technologies in complementary fields for further development and commercialization. To learn more, visit www.anixa.com or follow Anixa on Twitter, LinkedIn, Facebook and YouTube.
SOURCE Anixa Biosciences, Inc.

21 %

more press release views with

Frequently Asked Questions

Does Anixa Biosciences have accounts at Silicon Valley Bank?

No, Anixa Biosciences confirmed it does not have any accounts at Silicon Valley Bank.

What is Anixa Biosciences focused on?

Anixa Biosciences specializes in the treatment and prevention of cancer.

What cancer therapies is Anixa developing?

Anixa is developing ovarian cancer immunotherapy and breast cancer vaccines.

Who are Anixa's partners in developing therapies?

Anixa collaborates with Moffitt Cancer Center and Cleveland Clinic.

What is unique about Anixa's business model?

Anixa partners with research institutions to explore emerging cancer technologies.

Tags: ANIX Viatris Investor Conferences Healthcare Anixa Biosciences Silicon Valley Bank cancer treatment biotechnology immunotherapy
Last updated: Mar 13, 2023